一个非参数混合效应混合模型用于与COVID-19相关的临床测量模式
Xiaoran Ma1, Wensheng Guo2, Mengyang Gu1
1Department of Statistics and Applied Probability, University of California, Santa Barbara.
The annals of applied statistics
|October 10, 2024
概括
早期识别COVID-19症状子组至关重要. 一个新的统计模型有助于精确确定患有生物变化的患者,有助于早期检测感染并了解免疫反应.
科学领域:
- 传染性疾病 传染性疾病
- 生物统计学 生物统计学
- 免疫学 免疫学 免疫学
背景情况:
- 一些COVID-19患者在阳性SARS-CoV-2测试之前表现出早期临床症状,而另一些患者是无症状的.
- 了解这些子组及其预测因素对于早期检测和对免疫反应的洞察至关重要.
研究的目的:
- 开发一个统计模型来识别风险因素,并对患有与COVID-19相关的早期生物变化的患者进行分类.
- 调查不同患者亚组的预测因素及其不同的免疫反应.
主要方法:
- 提出了一个灵活的非参数混合效果混合模型.
- 使用逻辑回归建模的生物变化的潜伏概率;使用光滑斜线建模的轨迹.
- 一个预期最大化 (EM) 算法被开发用于参数估计.
主要成果:
- 该模型成功地识别了风险因素,并根据生物变化对患者进行分类.
- 模拟证明了该方法的有效性.
- 该模型用于分析COVID-19的血液透析患者的温度变化.
结论:
- 拟议的统计模型提供了一个强大的方法来识别COVID-19早期生物变化的患者子组.
- 这种方法可以提高感染个体的早期检测,并提供对差异性免疫反应的见解.
相关概念视频
Mechanistic Models: Compartment Models in Individual and Population Analysis
31
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
31
Statistical Methods for Analyzing Epidemiological Data
312
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
312
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
62
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
62
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
98
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
98
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
50
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
50
Clearance Models: Noncompartmental Models
45
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
45


